Stay updated with breaking news from Fibrosis Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kisspeptin hormone is found to have another promising function beyond puberty and fertility. Find out what it does against non-alcoholic fatty liver disease.
In Crohn’s disease (CD), intestinal fibrosis is a critical determinant of a patient’s prognosis. Although inflammation may be a prerequisite for the initiation of intestinal fibrosis, research shows that the progression or continuation of intestinal fibrosis can occur independently of inflammation. Thus, once initiated, intestinal fibrosis may persist even if medical treatment controls inflammation. Clearly, an understanding of the pathophysiological mechanisms of intestinal fibrosis is required to diminish its occurrence. Accumulating evidence suggests that the gut microbiota contributes ...
The FDA has accepted for review the New Drug Application for deucravacitinib for the treatment of adults with moderate to severe plaque psoriasis.
NEW YORK CITY (dpa-AFX) - Bristol Myers Squibb (BMY) said on Tuesday that the European Commission or EC has granted marketing authorization for ozanimod, brand named Zeposia for the treatment of
Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...